Midazolam Efficacy for Sedating Preschoolers Undergoing Dental Treatment

• Status: Completed
• Trial end date: 2013-02-01
• Target enrollment: 0
• Participant gender: All

Summary

Evaluation of oral midazolam to improve children's behavior and reduces the stress and anxiety during dental treatment

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Universidade Federal de Goias
• Collaborator: Federal University of Minas Gerais
• Treatments: Midazolam

Criteria

Inclusion Criteria:

• Children aged 2 to 5 years old, American Society of Anesthesiologists (ASA) I or II, healthy, with no cognitive impairment, presenting with early childhood caries

Exclusion Criteria:

• Children presenting with at least one of the following:

• airway obstruction and/or oral breathing;

• recent use of systemic corticosteroids

• needing less than two dental restorations;

• previous dental sedation.